MNOV
MEDICINOVA INC
+0.96 (+38.03%)3.48USD5.4M成交股數171M市值–本益比(近四季)214.8股價營收比+240.6%營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 458K | 187K | 123K | 135K | – | – | – | – | – | 1.0M | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 900K | 1.2M | 1.5M | 2.0M | 1.7M | 1.8M | 1.8M | 1.5M | 1.7M | 700K | 1.6M | 1.4M |
| 銷售管理費用 | 1.8M | 1.6M | 1.8M | 1.4M | 1.4M | 1.3M | 1.4M | 1.4M | 1.4M | 1.4M | 1.6M | 1.5M |
| 營業利益 | −2.5M-21% | −2.8M-11% | −3.4M+2% | −3.6M+18% | −3.2M+2% | −3.2M+178% | −3.3M+0% | −3.0M+3% | −3.1M | −1.1M | −3.3M | −3.0M |
| 營業利益率 | -554.3% | -1,516.6% | -2,741.7% | -2,679.9% | – | – | – | – | – | -114.7% | – | – |
| 稅後淨利 | −2.3M-19% | −2.6M-113% | −3.1M+7% | −3.3M+25% | −2.9M+4% | 19.3M-2767% | −2.9M-1% | −2.6M-10% | −2.8M | −723K | −2.9M | −2.9M |
| 淨利率 | -504.8% | -1,383.1% | -2,473.6% | -2,437.7% | – | – | – | – | – | -72.3% | – | – |
| 稀釋 EPS | -0.05-17% | -0.05-17% | -0.060% | -0.07+40% | -0.060% | -0.06+500% | -0.060% | -0.05-17% | -0.06 | -0.01 | -0.06 | -0.06 |
| 稀釋股數 | 49.2M | 49.2M | 49.0M | 49.0M | 49.0M | 49.0M | 49.0M | 49.0M | 49.0M | 49.0M | 49.0M | 49.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 25.4M | 27.3M | 32.6M | 34.3M | 36.6M | 40.4M | 42.3M | 44.3M | 47.1M | 51.5M | 52.9M | 55.3M |
| 應收帳款 | 0.00 | 245K | 0.00 | 135K | – | 0.00 | – | – | – | 1.0M | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 40.4M | 42.7M | 47.6M | 49.8M | 52.4M | 55.9M | 58.1M | 60.4M | 62.9M | 68.1M | 68.7M | 71.1M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 3.2M | 3.3M | 3.6M | 3.0M | 2.5M | 3.4M | 3.1M | 3.0M | 3.1M | 3.5M | 3.5M | 3.4M |
| 股東權益 | 37.3M | 39.4M | 44.0M | 46.9M | 49.9M | 52.5M | 55.1M | 57.4M | 59.8M | 64.7M | 65.2M | 67.7M |
| 負債比 | 7.8% | 7.7% | 7.6% | 6.0% | 4.8% | 6.0% | 5.3% | 5.0% | 4.9% | 5.1% | 5.2% | 4.8% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −3.5M | – | – | −3.8M-2% | – | – | – | −3.9M | – | – | −3.2M |
| 資本支出 | – | 11K | – | – | 0.00 | – | – | – | – | – | – | – |
| 自由現金流 | – | −3.5M | – | – | −3.8M | – | – | – | – | – | – | – |
| 折舊攤銷 | – | 4K | – | – | 5K | – | – | – | 5K | – | – | 4K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -1,861.7% | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 410K
| Reportable Segment Aggregation Before Other Operating | 410K | 100.0% | – |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 410K | – | 12.0M | 2,928.8% | -0.24 | −9.8M |
| FY2024 | – | – | 11.1M | –% | -0.23 | −10.6M |
| FY2023 | 1.0M | – | 8.6M | 857.2% | -0.17 | −7.5M |
| FY2022 | – | – | −14.1M | –% | -0.29 | −12.9M |
| FY2021 | 4.0M | – | −10.1M | -251.0% | -0.21 | −9.4M |
| FY2020 | – | – | −13.9M | –% | -0.31 | −10.9M |
| FY2019 | – | – | −12.9M | –% | -0.30 | −9.1M |
| FY2018 | – | – | −14.7M | –% | -0.36 | −9.1M |